Inventor
Wilson Burgess
Inventor
Clifton, VA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides21%
A61LMethods or apparatus for sterilising materials or objects in general15%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C12NMicroorganisms or enzymes9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
A61FFilters implantable into blood vessels4%
Y02ATechnologies for adaptation to climate change3%
A23BPreservation of foods, foodstuffs or non-alcoholic beverages2%
A61MDevices for introducing media into, or onto, the body2%
PatentTitleYear
7,848,487'Methods for sterilizing biological materials containing non-aqueous solvents'20107,252,799'Methods for sterilizing preparations containing albumin'20077,229,959'Supplemented fibrin matrix delivery systems'20077,196,054'Methods for treating wound tissue and forming a supplemented fibrin matrix'20077,189,410'Supplemented and unsupplemented tissue sealants, methods of their production and use'2007RE039321'Supplemented and unsupplemented tissue sealants, methods of their production and use'2006RE039298'Supplemented and unsupplemented tissue sealants, methods of their production and use'2006RE039192'Supplemented and unsupplemented tissue sealants, methods of their production and use'20066,982,170'Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1'20066,946,098'Methods for sterilizing biological materials'20056,908,591'Methods for sterilizing biological materials by irradiation over a temperature gradient'20056,783,968'Methods for sterilizing preparations of glycosidases'20046,749,851'Methods for sterilizing preparations of digestive enzymes'20046,696,060'Methods for sterilizing preparations of monoclonal immunoglobulins'20046,682,695'Methods for sterilizing biological materials by multiple rates'2004RE038240'DNA encoding human endothelial cell growth factors and plasmids comprising said DNA'2003RE037850'Recombinant human endothelial cell growth factor'20025,849,538'DNA encoding human endothelial cell growth factors and plasmids comprising said DNA'19985,827,826'Compositions of human endothelial cell growth factor'19985,656,598'Use of fibroblast growth factors to stimulate bone growth'19975,614,496'Use of fibroblast growth factors to stimulate bone growth'19975,599,708'Osteoclast growth regulating factors and antibodies'19975,571,790'Recombinant human endothelial cell growth factor'19965,552,528'Bovine b-endothelial cell growth factor'19965,408,041'Process of purifying antler-derived bone growth factors'19954,868,113'Recombinant DNA vector encoding human endothelial cell growth factor'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–1998Based in Gaithersburg, MD, US· patent location history
1995–1998Patents assigned to RHONE POULENC RORER PHARMA (7)· patent assignee history
1995–1997Patents assigned to OSTEOSA INC (3)· patent assignee history
1996Based in Gaithersborg, MD, US· patent location history
2002Patents assigned to AVENTIS PHARM PROD INC (1)· patent assignee history
2002–2010Based in Clifton, VA, US· patent location history
2004–2010Patents assigned to CLEARANT INC (8)· patent assignee history
2006–2007Patents assigned to AMERICAN NAT RED CROSS (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CLEARANT INC | 8 | 2004–2010 |
| RHONE POULENC RORER PHARMA | 7 | 1995–1998 |
| AMERICAN NAT RED CROSS | 6 | 2006–2007 |
| OSTEOSA INC | 3 | 1995–1997 |
| AVENTIS PHARM PROD INC | 1 | 2002 |
Locations
| Location | Patents | Span |
|---|---|---|
| Clifton, Virginia, US | 17 | 2002–2010 |
| Gaithersburg, Maryland, US | 8 | 1989–1998 |
| Gaithersborg, Maryland, US | 1 | 1996 |